Index
Module 20 • Toxicology
Toxicology
73%
Data Tables
Toxicology
Kyle Weant ~3 min read Module 20 of 20
36
/ 49

Toxicology

Suggested indications for the use of hemodialysis include (Chest 2008;133:1006-13):

Severe toxicity (severe altered mental status or seizures)

ii.

Renal failure (cannot eliminate lithium)

iii.

Lithium concentrations greater than 2.5 mmol/L in chronic exposures

iv.

Lithium concentrations greater than 4 mmol/L in acute exposures

C.Monitoring – Patients should be monitored for clinical improvement for at least 8–12 hours.
1

Monitor for cardiac toxicity with a 12-lead ECG, CK-MB, and troponins.

2Monitor for respiratory depression with RR and pulse oximetry.
3

Monitor renal function with urine output, BUN, and SCr.

4

Monitor baseline lithium concentrations and then every 6 hours after until concentrations have

decreased to less than 1.5 mmol/L (normal 0.6–1.2 mmol/L).

Patient Case

10A 24-year-old woman is brought to the ED by her roommate. She has been in a normal state of health, but

the roommate is concerned because she “seems really out of it.” According to the roommate, the patient had

an appointment with the physician today, and she had been given a prescription to refill olanzapine 5 mg by

mouth daily, but the bottle is empty. On physical examination, she is alert and oriented person, place and

time but she dozes off several times. Her vital signs are stable, and a 12-lead ECG shows sinus tachycardia.

Which intervention is most appropriate for this patient?

A.Lactated Ringer solution 500 mL intravenously
B.8.4% sodium bicarbonate 50 mL intravenously
C.Lorazepam 2 mg intravenously
D.Clinical monitoring for 6 hours
XV.ORAL HYPOGLYCEMICS
A.Background
1

Oral hypoglycemics accounted for 5944 single-agent exposures and 29 deaths in 2022.

2The most common oral hypoglycemic involved in toxic exposures was metformin, followed by the

sulfonylureas and the glucagon-like peptide-1 (GLP-1) receptor agonists.

3

The most serious adverse effects were reported with the sulfonylureas; however, most fatalities were

associated with metformin.

B.Clinical Presentation
1

Clinical signs and symptoms include hypoglycemia (not with metformin), nausea, vomiting, dizziness,

tachycardia, and diaphoresis.

2More severe adverse effects include seizures, palpitations, tachyarrhythmias, electrolyte abnormalities,

and metabolic (lactic) acidosis.

C.Treatment
1

Stabilization of the ABC

2Identifying the causative agent is important because specific treatment will vary by the agent involved.
3

Consider gastric decontamination with single-dose activated charcoal if patients present within 1 hour

of overdose.

4
Observe clinically asymptomatic patients for a minimum of 8 hours (Am J Health Syst Pharm

2006;63:929-38).

شرح الفيديو التعليمي — مزامنة مع الـ PDF
بدء التشغيل من: الدقيقة 35 فتح على YouTube